TCT-113 Focal Treatment of Lower Extremity Post-PTA Dissection Using The Tack-It Endovascular Staple Device: First-in-man Trial With One Year Follow-up  by Schneider, Peter et al.
improves overall DTB time and transfer time. In addition, it has the potential to decrease
the frequency of false activations, therefore improving cost-efficiency of a network’s
STEMI system.
TCT-113
Focal Treatment of Lower Extremity Post-PTA Dissection Using The Tack-It
Endovascular Staple Device: First-in-man Trial With One Year Follow-up
Peter Schneider1, Adrian Ebner2, Robert Giasolli3
1Kaiser Hawaii, Honolulu, HI, 2Italian Hospital, Asuncion, Paraguay, 3Intact
Vascular, Wayne, PA
Background: The purpose of this study was to evaluate the safety, feasibility, and results
of using the Tack-It Endovascular Stapler™ to manage post-PTA dissection. Stents are
used to manage of post-PTA dissection of the lower extremity arteries. This generally
provides an acceptable post-intervention angiographic result but has long-term disadvan-
tages such as in-stent restenosis and fracture. Focal treatment of post-PTA dissection and
avoidance of stent placement in this setting is the function of the Tack-It device.
Methods: A total of 15 limbs (11 patients) with 25 lesion treatment sites were treated
with the study device between December, 2009 and March, 2010. In the study group, 7
subjects had lesion treatments in one leg and 4 subjects had lesion treatments treated in
bilateral extremities for lesions of the SFA, popliteal, or tibial arteries or a combination of
these. Indications were CLI in 9 of the 15 limbs and claudication in 6.
Results: Acute technical success for luminal patency at the end of the study procedure
was achieved with Tack placement and tissue apposition in 100% of all treated
dissections. 50 Tacks were placed and placement was accurate in 96% (48/50). Tack
placement successfully provided a smooth, post-angioplasty blood vessel surface and
permanently secured post-PTA dissections. Mean procedure time was 51 minutes (range
10 – 128 minutes). Mean fluoroscopy time was 13 minutes (range 5 – 30 minutes). Two
patients died and 2 were lost to follow-up during the year after the procedure. There were
no device related complications. There were no major limb amputations. 18 of the 25
lesions were available for follow-up at one year. There was recurrent stenosis (50%) in
3 of 18. One patient with gangrene and a popliteal occlusion returned with a recurrent
stenosis at 3 months and required repeat angioplasty and Tack placement for a TLR rate
of 4%. Overall angiographic patency at one year was 83.3%.
Conclusions: Use of the Tack-It Endovascular Stapler™ to manage post-PTA dissec-
tions is safe and feasible, and resulted in permanent securement of dissection flaps without
stent placement and with reasonable angiographic patency at one-year.
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Feasibility of Noninvasive Atherectomy: Plaque Ablation with Cavitation-
Based Focused Ultrasound (Histotripsy)
Adam Maxwell1, Zhen Xu1, Hitinder Gurm1
1University of Michigan, Ann Arbor, MI
Background: Histotripsy is a novel technique that uses high-amplitude focused ultra-
sound pulses to create cavitation in a targeted tissue, with resultant mechanical breakdown
of the tissue structure. Ultrasound imaging provides feedback for the therapy, including
targeting and monitoring treatment progression. We assessed the feasibility of histotripsy
for ablating large vessel plaque.
Methods: Human plaque specimens obtained from carotid or femoral endarterectomy
were fixed to a gelatin substrate and placed in a water tank. In 4 samples, the focus was
scanned within the plaque to try to create a channel through it. In 3 samples, multiple fixed
focal ablations were performed to evaluate erosion rate. Histological analysis was
performed post treatment to examine ablation efficacy for different plaque types.
Results: Tissue breakdown was evident in most samples. Cavitation was observed by
B-Mode imaging on the surface or within the plaque volume during treatment, indicating
the region of disruption. Channels up to 1 cm were created within the bulk of the plaque.
Ablation rate was strongly dependent on plaque type: fatty material could be ablated
within a few seconds in the focus, while very fibrous material required5-15 minutes per
focal volume. No damage was observed to calcific material. The figure shows gross
morphology (left) and histology (right) of a channel created adjacent to the lumen in a
fibrous-fatty plaque.
Conclusions: Histotripsy provides a noninvasive method of ablation of atherosclerotic
plaque. We are currently exploring the feasibility of this technique for treatment of
femoral-popliteal disease.
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Hybrid endovascular repair for aortic arch pathology: intermediate outcomes
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Background: To evaluate the outcomes of hybrid endovascular repair for aortic arch
pathology.
Methods: This study was a retrospective analysis involving patients who underwent
hybrid endovascular repair for aortic arch pathologies.
Results: Twenty-one patients (16 men; mean age, 64.716.2 years) with aortic arch
pathologies were treated by hybrid endovascular repair. The indications for treatment
included increased aneurysm size in 16 cases (71.4%), rupture or impending aneurysmal
rupture in 5 cases (23.8%), and rapid growth of aortic dissection ( 10mm/y) in 1 case
(4.8%). Supra-aortic vessel transposition and stent-graft implantation were achieved in all
cases. Two types of stent-graft was used, as follows: the Seal thoracic stent-graft in 14
patients (66.7%); and the Valiant stent grafts in 7 patients (33.3%). Peri-operative
complications affected 5 patients (23.8%), as follows: bleeding (n4, 19.0%); stroke
(n3, 14.3%); renal failure (n2, 9.5%); vascular injury (n1, 4.8%), and respiratory
failure (n1, 4.8%). Two patients died within 30 days (9.5%). Technical success was
achieved in 15 patients (71.5%). Early endoleaks were noted in 4 patients (19.0%). One
patient died during follow-up (mean, 21.311.6 months) due to a de novo aortic
dissection. Persistent early endoleaks were noted in 4 patients (19.0%); 2 of the 4 patients
were successfully managed with implantation of additional stent-grafts. No late onset
endoleaks were noted.
Conclusions: Hybrid treatment with supra-aortic vessel transposition and endovascular
repair may be an option in frail patients in who open procedures is too risky.
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A New Concept Of Stent: The Multilayer Flow Modulator. First Human
Study In Thoraco Abdominal And Abdominal Aortic Aneurysms.
Michel Henry1, Amira Benjelloun2, Isabelle Henry3
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Background: Thoraco Abdominal Aortic Aneurysms (TAAA) and Abdominal Aortic
Aneurysms (AAA) are traditionally treated surgically, but more and more by interven-
tional procedures (endografts, fenestrated grafts) with a high technical success rate but
high complications rate (mortality 9-12%, endoleacks 10-20%, branch occlusion 3-11%,
neurological complications 5-11%). We developed a new concept of stent, the Multilayer
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